Sara Pellegrino | executive |
Frederick Vogt | executive |
James Ziegler | executive |
Igor Bilinsky | executive |
Jean-Marc Bellemin | executive |
Friedrich Graf Finckenstein | executive |
Michael Yee | analyst |
Peter Lawson | analyst |
Andrea Tan | analyst |
Yanan Zhu | analyst |
Tyler Van Buren | analyst |
Benjamin Burnett | analyst |
Colleen Hanley | analyst |
Asthika Goonewardene | analyst |
Reni Benjamin | analyst |
Brian Gastman | executive |
Welcome to the Iovance Biotherapeutics conference call to discuss second quarter 2024 results and recent corporate updates. My name is Daniel, and I will be your operator for today's call. [Operator Instructions] Please note that this conference is being recorded. I will now turn the call over to Sara Pellegrino, Senior Vice President, Investor Relations and Corporate Communications at Iovance. Sara, you may begin.